Chemistry Wealth Management’s iShares MSCI EAFE ETF EFA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$804K Sell
7,743
-97
-1% -$9.98K 0.13% 103
2026
Q1
$761K Hold
7,840
0.13% 96
2025
Q4
$753K Sell
7,840
-356
-4% -$33.8K 0.14% 100
2025
Q3
$765K Hold
8,196
0.15% 93
2025
Q2
$733K Hold
8,196
0.16% 91
2025
Q1
$670K Buy
8,196
+233
+3% +$18.8K 0.16% 88
2024
Q4
$602K Buy
7,963
+1,662
+26% +$132K 0.14% 90
2024
Q3
$527K Hold
6,301
0.12% 100
2024
Q2
$494K Sell
6,301
-170
-3% -$13.5K 0.13% 98
2024
Q1
$517K Hold
6,471
0.14% 95
2023
Q4
$488K Hold
6,471
0.15% 91
2023
Q3
$446K Hold
6,471
0.15% 90
2023
Q2
$469K Hold
6,471
0.15% 91
2023
Q1
$463K Buy
6,471
+66
+1% +$4.62K 0.16% 94
2022
Q4
$420K Hold
6,405
0.16% 93
2022
Q3
$359K Sell
6,405
-155
-2% -$9.66K 0.14% 102
2022
Q2
$410K Hold
6,560
0.16% 98
2022
Q1
$483K Buy
6,560
+3,037
+86% +$227K 0.17% 88
2021
Q4
$277K Buy
+3,523
New +$279K 0.23% 71

Other funds holding EFA

Chemistry Wealth Management's EFA Position: Q2 2026 in Review

Chemistry Wealth Management reduced its iShares MSCI EAFE ETF (EFA) stake by 1.2% in Q2 2026, selling an estimated $9.98K and leaving 7,743 shares worth $804K. The position accounts for 0.13% of the portfolio, ranked #103.

Chemistry Wealth Management first reported a position in EFA in Q4 2021 and has held it in 19 quarters since. 1,207 funds tracked by Wall St. Rank hold EFA as of Q2 2026.

  • Chemistry Wealth Management held 7,743 shares of iShares MSCI EAFE ETF worth $804K as of Q2 2026.
  • Chemistry Wealth Management sold 97 iShares MSCI EAFE ETF shares in Q2 2026, an estimated $9.98K.
  • iShares MSCI EAFE ETF made up 0.13% of Chemistry Wealth Management's portfolio in Q2 2026, its #103 holding.
  • Chemistry Wealth Management first reported a position in iShares MSCI EAFE ETF in Q4 2021 and has held it in 19 quarters since.
  • 1,207 funds tracked by Wall St. Rank held iShares MSCI EAFE ETF as of Q2 2026.

Based on Chemistry Wealth Management's 13F filing for Q2 2026, filed 9 Jul 2026.